Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if metformin reduces adverse outcomes associated with
prediabetes in pregnancy. Our hypothesis is that pregnant women with prediabetes who are
treated with metformin will show a greater reduction in large for gestational age infants at
birth compared to women treated with the standard of care.